Literature DB >> 12242695

Hypoxia-induced pathways in breast cancer.

T I Goonewardene1, H M Sowter, A L Harris.   

Abstract

Hypoxia, a common consequence of solid tumor growth in breast cancer and other cancers, serves to propagate a cascade of molecular pathways which include angiogenesis, glycolysis, and alterations in microenvironmental pH. Hypoxia-inducible factors, heterodimeric DNA binding complexes composed of two subunits, provide critical regulation of this response. This review presents a synopsis of the genes induced by hypoxia in the context of breast cancer and discusses how upregulation of HIF-1 activity, and the homologous factor HIF-2, are not only fundamental for the adaptation to hypoxia but also may be critical for tumor progression. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242695     DOI: 10.1002/jemt.10175

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  18 in total

1.  Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.

Authors:  Bénédicte F Jordan; Matthew Runquist; Natarajan Raghunand; Amanda Baker; Ryan Williams; Lynn Kirkpatrick; Garth Powis; Robert J Gillies
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

2.  Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.

Authors:  Narges K Tafreshi; Marilyn M Bui; Kellsey Bishop; Mark C Lloyd; Steven A Enkemann; Alexis S Lopez; Dominique Abrahams; Bradford W Carter; Josef Vagner; Stephen R Grobmyer; Stephen R Gobmyer; Robert J Gillies; David L Morse
Journal:  Clin Cancer Res       Date:  2011-10-20       Impact factor: 12.531

Review 3.  Employing tumor hypoxia for oncolytic therapy in breast cancer.

Authors:  Yun Shin Chun; Prasad S Adusumilli; Yuman Fong
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

4.  The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes.

Authors:  Anna Grazia Recchia; Ernestina Marianna De Francesco; Adele Vivacqua; Diego Sisci; Maria Luisa Panno; Sebastiano Andò; Marcello Maggiolini
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

5.  The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance.

Authors:  Kelly A Whelan; Luciana P Schwab; Sergey V Karakashev; Lisa Franchetti; Gregg J Johannes; Tiffany N Seagroves; Mauricio J Reginato
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

6.  Hypoxia induces differential translation of enolase/MBP-1.

Authors:  Kara C Sedoris; Shelia D Thomas; Donald M Miller
Journal:  BMC Cancer       Date:  2010-04-22       Impact factor: 4.430

7.  Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis.

Authors:  Kelly A Whelan; Sarah A Caldwell; Kristina S Shahriari; S RaElle Jackson; Lisa D Franchetti; Gregg J Johannes; Mauricio J Reginato
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

8.  Cytotoxicity of lymphocytes activated by superantigen toxic-shock-syndrome toxin-1 against colorectal cancer LoVo cells.

Authors:  Wei Wang; Xuejun Sun; Le Lu; Jian-Bao Zheng; Yong Tian; Wei Wang
Journal:  Mol Cell Biochem       Date:  2013-01-24       Impact factor: 3.396

9.  Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells.

Authors:  Ke Liang; Songbo Qiu; Yang Lu; Zhen Fan
Journal:  Cancer Biol Ther       Date:  2013-10-22       Impact factor: 4.742

Review 10.  Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.

Authors:  Narges K Tafreshi; Mark C Lloyd; Marilyn M Bui; Robert J Gillies; David L Morse
Journal:  Subcell Biochem       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.